Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesTesamorelin Explained: Deep Dive into Fat Loss & Longevity by 2026
Tesamorelin, a synthetic GHRH analogue, offers a targeted approach to reducing visceral fat and optimising the growth hormone axis. This deep dive unpacks its science.
PeptidesCJC-1295: 2026’s Latest Evidence on Growth
Dive into the newest 2026 evidence surrounding CJC-1295 with DAC, examining its role in growth hormone modulation, clinical efficacy, and safety profile.
PeptidesCJC-1295: Latest 2026 Evidence and Revised
Dive into the cutting-edge research on CJC-1295, focusing on breakthroughs and revised recommendations emerging in 2026 for healthspan optimisation.
PeptidesCJC-1295: Latest Clinical Evidence & Safety
Dive into the latest 2026 clinical evidence for CJC-1295 with DAC, examining its mechanisms, revised benefits, and safety considerations for healthspan optimisation.
PeptidesCJC-1295 in 2026: Unpacking the Latest Evidence
Dive into the cutting-edge research on CJC-1295 (with DAC) from 2025-2026, examining new clinical trials, revised recommendations, and its place in longevity strategies.
PeptidesIpamorelin's Biomarker Impact: Longevity
Could Ipamorelin influence key longevity biomarkers? We scrutinise its impact on IGF-1, inflammation, and cellular ageing, assessing the evidence for its role in healthspan.
PeptidesIpamorelin Dosing Protocols for Healthspan in
Dive into the nuanced world of Ipamorelin dosing, covering clinically studied ranges, titration, timing, and cycling for longevity, performance, and recovery. Learn how to optimise your protocol.
PeptidesCJC-1295 & Sleep Architecture: Optimising
CJC-1295, a long-acting GHRH analogue, is often discussed for muscle and recovery. This post delves into its specific, nuanced effects on sleep architecture.
PeptidesCJC-1295 and Longevity Biomarkers: Outlook for
CJC-1295 is a synthetic GHRH analogue. This deep-dive examines its documented and speculative effects on critical longevity biomarkers, offering a scientific perspective for 2026.
PeptidesCJC-1295 UK Availability & Cost: Navigating
Understanding CJC-1295 in the UK for 2026: legalities, sourcing, costs, and safety precautions for this growth hormone-releasing peptide.
PeptidesIpamorelin Stacking Strategies for Healthspan
Ipamorelin, a selective GH secretagogue, offers significant anti-aging potential. This deep dive explores its synergy with other compounds for enhanced healthspan benefits.
PeptidesCJC-1295 Ipamorelin Growth Hormone Safety: A
CJC-1295 Ipamorelin is a popular peptide combination for growth hormone release. This review examines its safety, efficacy, and potential side effects.
PeptidesCJC-1295 Stacks: Synergistic Longevity for 2026
Discover how CJC-1295 can be strategically stacked with other compounds to amplify its benefits for longevity, focusing on cognitive function, recovery, and metabolic health.
PeptidesIpamorelin for Sleep: A 2026 Perspective on
Ipamorelin, a selective GH secretagogue, offers a nuanced approach to optimising sleep. We examine its effects on deep sleep, REM, and hormonal interplay.
PeptidesIpamorelin's Cognitive Promise: Focus
Ipamorelin, a selective growth hormone secretagogue, is gaining attention for its potential neurocognitive benefits. We analyse the research.
PeptidesIpamorelin for Women: Unlocking Healthspan in
Ipamorelin, a selective GH secretagogue, offers unique benefits for women, particularly around hormonal shifts like perimenopause and menopause, by subtly boosting growth hormone.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.